INSY | Insys Therapeutics Inc

• Summary
• Earnings Call
• Events
• Charts
• Historical Data
• Dividends
• Profile

Category: Healthcare

Quick infos

• Headquarters:   Phoenix, Arizona, United States

Trade prices

• Volume:
• Market Cap: 419.62M
• Prev closed: 5.74
• Open: 5.7
• High: 5.72
• Low: 5.48
• 52 week low: 3.35
• 52 week high: 11.65
• Dividends:No Dividends

Next ER: March 10, 2020 

Top Stories (INSY)

About the Company

Insys Therapeutics is an American specialty pharmaceutical company based in Chandler, Arizona.

Earnings History

Date	EPS / Forecast	Revenue / Forecast
March 10, 2020	- / -0.43	- / 3.5M
November 29, 2019	- / -0.44	- / 4.5M
August 28, 2019	- / -0.44	- / 5.5M
August 12, 2019	- / -0.44	- / 5.5M
May 10, 2019	-0.55 / -0.22	7.63M / 13.9M
view more

Historical Data

Date		Price		Open	High	Low		Vol	Change	ER
Feb 18, 2020		0.05		0.04	0.05	0.04		105.34K	0%
Feb 14, 2020		0.05		0.04	0.05	0.04		76.59K	25%
Feb 13, 2020		0.04		0.05	0.05	0.04		46.03K	-20%
Feb 12, 2020		0.05		0.04	0.05	0.04		177.84K	25%
Feb 11, 2020		0.04		0.04	0.04	0.04		-	-20%
Feb 10, 2020		0.05		0.04	0.05	0.04		7.42K	25%
Feb 7, 2020		0.04		0.05	0.05	0.04		75.47K	-20%
Feb 6, 2020		0.05		0.04	0.05	0.04		60.63K	0%
Feb 5, 2020		0.05		0.04	0.06	0.04		127.95K	0%
Feb 4, 2020		0.05		0.04	0.06	0.04		132.62K	25%
view more

Show all

NASDAQ - Nasdaq Stock Market

News

News for (INSY)

• Recent Research Analysts’ Ratings Changes for Insys Therapeutics (INSY)
  mayfieldrecorder.com Jun 6, 2019 8:18 am
• Midday Gainers / Losers
  seekingalpha.com Mar 14, 2019 12:47 am
• INSYS continues selloff from near-term rally, down 12%
  seekingalpha.com Mar 13, 2019 11:01 pm
• Insys Therapeutics (NASDAQ:INSY) Shares Plunge After Auditor Raises Viability Concerns
  benzinga.com Mar 13, 2019 7:26 pm
• INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency ...
  globenewswire.com Feb 25, 2019 12:54 pm
• DVN, LYG among premarket gainers
  seekingalpha.com Feb 20, 2019 10:21 pm
• In Hindsight Maybe This Pro-Fentanyl Rap Video Made by a Pharma Company Wasn't the Best Look
  gizmodo.com Feb 18, 2019 7:54 pm
• Opioid trial testimony: Insys exec gave doctor lap dance to promote drug
  seekingalpha.com Jan 30, 2019 7:21 am
• Study links opioid prescriptions to marketing spend
  seekingalpha.com Jan 19, 2019 1:43 am

This company doesn't provide a dividend.

Talk about Insys Therapeutics Inc below in comments section below.

Do you think you'll buy? Do you already have active trades now?

EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.

Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.

Other ER on Mar 10, 2020 (Same day)